A detailed history of Omni 360 Wealth, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Omni 360 Wealth, Inc. holds 2,444 shares of ABBV stock, worth $571,896. This represents 0.32% of its overall portfolio holdings.

Number of Shares
2,444
Previous 2,831 13.67%
Holding current value
$571,896
Previous $525 Million 7.72%
% of portfolio
0.32%
Previous 0.26%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 20, 2025

SELL
$184.85 - $231.54 $71,536 - $89,605
-387 Reduced 13.67%
2,444 $566 Million
Q2 2025

Jul 07, 2025

SELL
$170.16 - $206.27 $8,167 - $9,900
-48 Reduced 1.67%
2,831 $525 Million
Q1 2025

Oct 27, 2025

SELL
$169.2 - $216.66 $4,906 - $6,283
-29 Reduced 1.13%
2,536 $531 Million
Q1 2025

Apr 30, 2025

BUY
$169.2 - $216.66 $9,982 - $12,782
59 Added 2.09%
2,879 $603 Million
Q4 2024

Oct 27, 2025

SELL
$164.99 - $203.87 $52,631 - $65,034
-319 Reduced 11.06%
2,565 $456 Million
Q4 2024

Feb 14, 2025

SELL
$164.99 - $203.87 $37,617 - $46,482
-228 Reduced 7.48%
2,820 $501 Million
Q3 2024

Oct 27, 2025

BUY
$163.84 - $199.33 $7,864 - $9,567
48 Added 1.69%
2,884 $570 Million
Q3 2024

Oct 24, 2024

BUY
$163.84 - $199.33 $16,384 - $19,933
100 Added 3.39%
3,048 $602 Million
Q2 2024

Oct 27, 2025

BUY
$154.79 - $180.76 $9,287 - $10,845
60 Added 2.16%
2,836 $486 Million
Q2 2024

Jul 19, 2024

BUY
$154.79 - $180.76 $17,026 - $19,883
110 Added 3.88%
2,948 $506 Million
Q1 2024

Oct 27, 2025

SELL
$159.82 - $182.1 $7,671 - $8,740
-48 Reduced 1.7%
2,776 $505 Million
Q1 2024

Apr 19, 2024

SELL
$159.82 - $182.1 $3,995 - $4,552
-25 Reduced 0.87%
2,838 $517 Million
Q4 2023

Oct 27, 2025

BUY
$137.6 - $154.97 $52,288 - $58,888
380 Added 15.55%
2,824 $438 Million
Q4 2023

Feb 08, 2024

BUY
$137.6 - $154.97 $393,948 - $443,679
2,863 New
2,863 $444 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $414B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Omni 360 Wealth, Inc. Portfolio

Follow Omni 360 Wealth, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Omni 360 Wealth, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Omni 360 Wealth, Inc. with notifications on news.